Home > Insider Trading > Filing (0001209191-20-033717)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Therapeutics Public Ltd Co	HZNP	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1769107	Jeff Kent	C/O Horizon Therapeutics Plc Connaught House, 1St Fl, 1 Burlington Rd Dublin L2 4	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Ordinary Shares	Disposition	2020-06-01	49,115	$49.83	69,094	No	4	S	Direct
Ordinary Shares	Disposition	2020-06-01	8,100	$50.59	60,994	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 14, 2020.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.39 to $50.38 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Includes 1,049 ordinary shares of the Issuer acquired by the reporting person on June 1, 2020 pursuant to an employee stock purchase program.
The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $50.39 to $50.775 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.